Order of the Government of the Russian Federation dated 12.10.2019 N 2406-r
(as amended by Russian Government Orders of 26.04.2020 No. 1142-r, of 12.10.2020 No. 2626-r, of 23.11.2020 No. 3073-r, of 23.12.2021 No. 3781-r, of 30.03.2022 No. 660-r, of 24.08.2022 No. 2419-r, of 06.10.2022 No. 2927-r, of 24.12.2022 No. 4173-r, of 09.06.2023 No. 1508-r, of 16.04.2024 No. 938-r, of 15.01.2025 No. 10-r)
list of vital and essential drugs for medical use in accordance with Appendix No. 1; (as amended by the Order of the Government of the Russian Federation from 12.10.2020 N 2626-r)
Paragraph. - No longer in effect. (as amended by the Order of the Government of the Russian Federation from 23.11.2020 N 3073-r)
a list of medicinal products intended to provide individuals with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic uremic syndrome, juvenile arthritis of systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stewart-Prower), individuals after organ and (or) tissue transplantation, in accordance with Appendix No. 3; (as amended by the Order of the Government of the Russian Federation from 26.04.2020 N 1142-r)
the minimum range of medicinal products necessary for the provision of medical care, in accordance with Appendix No. 4.
2. To declare the order of the Government of the Russian Federation invalid from December 10, 2018 N 2738-r (Collection of Legislation of the Russian Federation, 2018, No. 51, Art. 8075).
3. This order comes into force on January 1, 2020.
Appendix 1. List of vital and essential drugs for medical use
Appendix 4. Minimum range of medicinal products required to provide medical care